Several AEs were associated with genetic variability in the SLC22A1. The rs628031 AA genotype increased risk for OH, PE, and ICDs, whereas GA genotype appeared to be protective against dyskinesia. The gene discussed is SLC22A1; the disease is drug-induced dyskinesia.